# AZ's R&D chief Barr touts internal 'science success story' after IL-33 antibody's stellar showing in COPD

> **Newsylist Open Intelligence Dossier** · First detected: 2026-09-09 06:29 UTC · Category: Business · Sources: 2 · Current Velocity: 0.71

## Multi-Source Evidence Table
| Source Outlet | Headline | Published (UTC) | Verification URL |
|---|---|---|---|
| Reuters | NEWSLETTER: AstraZeneca drug reduces lung disease flare-ups in late-stage trials | 2026-09-08 14:50 | [Source Link](https://news.google.com/rss/articles/CBMi0wFBVV95cUxOMS1zMUx0aVE0MmkxaVVGRWJfNTBBQmJpNXFaZDcyZVY5UzZ0cnZjYWJzVjJVcE83UFdnemVYMm9rSWhET05iU29YMk9jekFwOUM5djRmbjZlcTM0cGVMUUJFVWx0WnhEdWpjVHlSWkl0QUR6NGlLLVpDUnZjNXZmQmxCX21WanRLTHd5ZEpLaUJzNkZlVTRXNlEzeDU1R29ScnFCcUZ0WDhVOXNjcEVyMnBVRUpzR0ZFTmpfWkd2SEwxeWRYR1VseGVQMHZiMDVTVGNB?oc=5) |
| firstwordpharma.com | AstraZeneca's tozorakimab cuts COPD exacerbations in Phase III studies | 2026-09-08 14:50 | [Source Link](https://news.google.com/rss/articles/CBMiU0FVX3lxTE1zZUFYR1BjTWpCRHB5QTVmTkN4QldOel96Wm5CeXdkYnNDOEswQlJvc0xvbjBqaHZFSzZUYmo2RGRtVEx3WVpya0Y0a29IVnNkU3BV?oc=5) |

---
*Canonical Source: https://www.newsylist.com/trend/2026-09-09/az-s-r-d-chief-barr-touts-internal-science-success-story-after-il-33-antibody-s*
*Synthesized by Newsylist Open Intelligence Engine under E-E-A-T journalistic standards.*